BMI1 and breast carcinoma: In vivo experiments also confirmed that silencing of BMI1 expression decreased cell proliferation and spherogenesis of cells resistant to radiation by affecting Hhg signaling pathway, suggesting that BMI1 may play an important role as a key target in the treatment of breast cancer with radiation and temozolomide.